Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels

Learn about ‘free pipeline’ investment.

The stock market rout pushed down shares of biotechnology companies by as much as 20%.

Tap image for article.


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.